JAK2 and head and neck squamous cell carcinoma: As proof of concept, we showed that expression of JAK2, an established driver of CD274 transcription [7,8], correlates significantly with CD274 expression in HNSCC (Pearson r = 0.69, p < 0.0001; Figure S2A).